Citizens Financial Group Inc. RI Sells 1,799 Shares of CVS Health Co. (NYSE:CVS)

Citizens Financial Group Inc. RI lowered its position in CVS Health Co. (NYSE:CVS) by 1.9% in the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 93,437 shares of the pharmacy operator’s stock after selling 1,799 shares during the period. Citizens Financial Group Inc. RI’s holdings in CVS Health were worth $7,378,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in CVS. SOA Wealth Advisors LLC. increased its holdings in shares of CVS Health by 4.9% in the fourth quarter. SOA Wealth Advisors LLC. now owns 2,859 shares of the pharmacy operator’s stock worth $226,000 after purchasing an additional 133 shares during the last quarter. Apella Capital LLC increased its holdings in shares of CVS Health by 4.2% in the fourth quarter. Apella Capital LLC now owns 3,378 shares of the pharmacy operator’s stock worth $272,000 after purchasing an additional 136 shares during the last quarter. Prairie Sky Financial Group LLC increased its stake in CVS Health by 4.1% during the fourth quarter. Prairie Sky Financial Group LLC now owns 3,612 shares of the pharmacy operator’s stock worth $285,000 after acquiring an additional 141 shares during the last quarter. WealthShield Partners LLC increased its stake in CVS Health by 3.2% during the fourth quarter. WealthShield Partners LLC now owns 4,498 shares of the pharmacy operator’s stock worth $355,000 after acquiring an additional 141 shares during the last quarter. Finally, Sugarloaf Wealth Management LLC increased its stake in CVS Health by 9.5% during the fourth quarter. Sugarloaf Wealth Management LLC now owns 1,639 shares of the pharmacy operator’s stock worth $129,000 after acquiring an additional 142 shares during the last quarter. Institutional investors own 80.66% of the company’s stock.

Analyst Ratings Changes

CVS has been the topic of several analyst reports. SVB Leerink initiated coverage on CVS Health in a research note on Monday, February 26th. They set an “outperform” rating and a $88.00 price objective on the stock. Leerink Partnrs reissued an “outperform” rating on shares of CVS Health in a research note on Monday, February 26th. Cantor Fitzgerald reissued an “overweight” rating and set a $87.00 price objective on shares of CVS Health in a research note on Wednesday, April 10th. Royal Bank of Canada reduced their price objective on CVS Health from $86.00 to $84.00 and set an “outperform” rating on the stock in a research note on Thursday, February 8th. Finally, StockNews.com lowered CVS Health from a “buy” rating to a “hold” rating in a research report on Thursday, February 15th. Four equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $89.44.

CVS Health Stock Down 0.2 %

Shares of NYSE CVS opened at $67.18 on Friday. The company has a debt-to-equity ratio of 0.77, a quick ratio of 0.63 and a current ratio of 0.86. The firm has a market capitalization of $84.68 billion, a price-to-earnings ratio of 10.40, a PEG ratio of 0.89 and a beta of 0.52. The stock has a 50 day moving average price of $74.42 and a 200 day moving average price of $73.66. CVS Health Co. has a 52-week low of $64.41 and a 52-week high of $83.25.

CVS Health (NYSE:CVS) last announced its quarterly earnings results on Wednesday, February 7th. The pharmacy operator reported $2.12 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.01 by $0.11. The firm had revenue of $93.81 billion during the quarter, compared to analyst estimates of $90.58 billion. CVS Health had a return on equity of 15.25% and a net margin of 2.33%. CVS Health’s quarterly revenue was up 11.9% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.99 earnings per share. Sell-side analysts expect that CVS Health Co. will post 8.31 earnings per share for the current year.

CVS Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, May 1st. Shareholders of record on Monday, April 22nd will be issued a dividend of $0.665 per share. The ex-dividend date is Friday, April 19th. This represents a $2.66 dividend on an annualized basis and a yield of 3.96%. CVS Health’s dividend payout ratio is currently 41.18%.

Insiders Place Their Bets

In other CVS Health news, EVP Prem S. Shah sold 29,473 shares of the company’s stock in a transaction on Friday, February 16th. The stock was sold at an average price of $76.95, for a total transaction of $2,267,947.35. Following the completion of the sale, the executive vice president now owns 39,765 shares in the company, valued at $3,059,916.75. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. 0.24% of the stock is owned by company insiders.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.